Combined Therapeutics

📍 Boston, United States🗓 Founded 2016👥 14 employees💰 Last funded Jan 2017
Biotechnology Research🌐 combinedtx.com
Website LinkedIn
Combined Therapeutics has developed a unique modified mRNA platform which targets protein expression to specific tissues while reducing off target effects. Together with our partners, we are committed to using our platform to protect vulnerable populations from global infectious disease threats as well as to cure cancer.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
1
Frequently asked questions
Who invested in Combined Therapeutics?
Combined Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Combined Therapeutics last raise funding?
The most recent investment in Combined Therapeutics recorded on gritt.io was in January 2017.
When was Combined Therapeutics founded?
Combined Therapeutics was founded in 2016.
What industry is Combined Therapeutics in?
Combined Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Combined Therapeutics based?
Combined Therapeutics is headquartered in Boston, United States.